Clinical Study on the Evaluation of the Efficacy of Cervical Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

4,000

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

February 16, 2029

Study Completion Date

February 16, 2030

Conditions

Uterine Cervical Neoplasms

Interventions

OTHER

Observational study

Our study does not have any exposure factors.

All Listed Sponsors

collaborator

Gansu Maternal and Child Health Hospital

UNKNOWN

collaborator

Hanzhong Central Hospital

OTHER

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT06254729 - Clinical Study on the Evaluation of the Efficacy of Cervical Cancer | Biotech Hunter | Biotech Hunter